 |
BioWorld-Insight-2010-06-28
Big Pharma Deals and Phase III Data Sweeten Diabetes Space
Biotech - Big Pharma Collaborations: Modified And Terminated Agreements, June 1 - 25, 2010#
No Abstract
Phase II Gene-Therapy Wins: Father, Son Harvest Research
Neurologix Inc.'s Phase II victory last week with NLX-P101 brought a much-needed credibility boost for gene therapy in Parkinson's disease and closely followed good news at the same clinical stage in advanced heart failure from Celladon Corp. with partner Targeted Genetics Corp.